Close Asset Management LTD Pfizer Inc Transaction History

Close Asset Management LTD

$3.25 Billion
Q3 2024

A detailed history of Close Asset Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Close Asset Management LTD holds 215,184 shares of PFE stock, worth $5.41 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

215,184

Previous 217,073 0.87%

Holding current value

$5.41 Million

Previous $6.08 Million 2.49%

% of portfolio

0.19%

Previous 0.21%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $52,325 - $59,295	-1,889 Reduced 0.87%	215,184 $6.23 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $576,205 - $675,205	-22,811 Reduced 9.51%	217,073 $6.08 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $725,955 - $833,629	-28,040 Reduced 10.47%	239,884 $6.65 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $1.18 Million - $1.54 Million	-45,312 Reduced 14.47%	267,924 $7.71 Million
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $176,912 - $206,792	-5,513 Reduced 1.73%	313,236 $10.4 Million
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $191,724 - $221,821	-5,308 Reduced 1.64%	318,749 $11.7 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $12.8 Million - $16.6 Million	324,057 New	324,057 $13.2 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $15 Million - $17.8 Million	-322,320 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $1.04 Million - $1.54 Million	-25,077 Reduced 7.22%	322,320 $19 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $130,820 - $168,049	-3,333 Reduced 0.95%	347,397 $14.9 Million
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $141,557 - $160,360	-3,942 Reduced 1.11%	350,730 $13.7 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $84,059 - $94,802	-2,510 Reduced 0.7%	354,672 $12.9 Million
Q4 2020 Jan 22, 2021	BUY	$33.47 - $42.56 $738,549 - $939,128	22,066 Added 6.58%	357,182 $13.1 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $84,994 - $99,718	-2,677 Reduced 0.79%	335,116 $12.3 Million
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $164,455 - $199,508	5,460 Added 1.64%	337,793 $11 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $297,870 - $425,592	-11,020 Reduced 3.21%	332,333 $10.3 Million
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $200,713 - $227,783	6,097 Added 1.81%	343,353 $13.4 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $563,376 - $730,534	-17,340 Reduced 4.89%	337,256 $12.1 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $1.47 Million - $1.65 Million	39,781 Added 12.64%	354,596 $15.4 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $11.2 Million - $12.4 Million	299,818 Added 1999.19%	314,815 $13.4 Million
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $16.6 Million - $19 Million	-432,124 Reduced 96.65%	14,997 $385,000
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $280,999 - $340,835	-8,152 Reduced 1.79%	447,121 $17.6 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $282,658 - $327,923	-8,858 Reduced 1.91%	455,273 $15.9 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $979,506 - $1.04 Million	-29,450 Reduced 5.97%	464,131 $16.8 Million
Q3 2017 Feb 13, 2018	BUY	$31.0 - $34.15 $9.27 Million - $10.2 Million	299,050 Added 153.73%	493,581 $0
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $9.37 Million - $10.3 Million	-302,164 Reduced 60.83%	194,531 $6.94 Million
Q2 2017 Feb 13, 2018	BUY	N/A	286,706 Added 136.53%	496,695 $16.7 Million
Q2 2017 Nov 14, 2017	SELL	N/A	-289,596 Reduced 57.97%	209,989 $0
Q1 2017 Feb 13, 2018	BUY	N/A	288,415 Added 136.58%	499,585 $17.1 Million
Q1 2017 Nov 14, 2017	SELL	N/A	-33,934 Reduced 13.84%	211,170 $7.22 Million
Q4 2016 Nov 14, 2017	BUY	N/A	245,104	245,104 $7.97 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.

Account

Close Asset Management LTD Pfizer Inc Transaction History